[ACS] From Obscurity to Opportunity: LpxH Emerges as a Promising Antibiotic Target in the Battle against Gram-Negative Pathogens |
10
Development of a Commercial Manufacturing Process for Vepdegestrant, an Orally Bioavailable PROTAC Estrogen Receptor Degrader for the Treatment of Breast Cancer
10
From Obscurity to Opportunity: LpxH Emerges as a Promising Antibiotic Target in the Battle against Gram-Negative Pathogens
10
Poly(vinyl alcohol) Hydrogels Enhanced with Ti3C2TxMXene Nanosheets and Aramid Nanofibers for Electromagnetic Shielding and Motion Detection
10
Local VibrationModes for Determining theGeGa+ FingerprintPeak in Gallium Nitride (GaN) via First-Principles Calculations